Lilian Gien (@lgienmd) 's Twitter Profile
Lilian Gien

@lgienmd

ID: 1299495724716044288

calendar_today28-08-2020 23:55:14

15 Tweet

16 Followers

43 Following

NEJM (@nejm) 's Twitter Profile Photo

Late breaking at #SGOMtg: In patients with advanced or recurrent endometrial cancer, the addition of pembrolizumab to standard chemotherapy resulted in significantly longer progression-free survival than chemotherapy alone. nej.md/3FJ4J3R

Late breaking at #SGOMtg: In patients with advanced or recurrent endometrial cancer, the addition of pembrolizumab to standard chemotherapy resulted in significantly longer progression-free survival than chemotherapy alone.  nej.md/3FJ4J3R
Cancer Research Institute (@cancerresearch) 's Twitter Profile Photo

"I am creating a world #Immune2Cancer by developing novel immunotherapy treatment strategies for women with gynecologic cancers, including cervical, endometrial, and ovarian," shares CRI Clinical Accelerator Investigator Dmitriy Zamarin MD PhD Memorial Sloan Kettering Cancer Center: bit.ly/3Mjt6ri

"I am creating a world #Immune2Cancer by developing novel immunotherapy treatment strategies for women with gynecologic cancers, including cervical, endometrial, and ovarian," shares CRI Clinical Accelerator Investigator <a href="/DmitriyZamarin/">Dmitriy Zamarin MD PhD</a> <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a>: bit.ly/3Mjt6ri